Phase 1/2: CD45RA Depleted Stem Cell Addback to Prevent Viral or Fungal Infections Post TCRab/CD19 Depleted HSCT
Children's Hospital of Philadelphia
Children's Hospital of Philadelphia
Memorial Sloan Kettering Cancer Center
Baylor College of Medicine
Columbia University
Bellicum Pharmaceuticals
Bellicum Pharmaceuticals